In a study led by Charlton et al., the assessment of the rate of synthesis of apoB100 unveiled lower rates in individuals with MASH compared to both obese and lean counterparts, indicating a potential implication of apoB100 synthesis in MASH development [202]. Here, APOB is linked to metabolic dysfunction-associated steatohepatitis.